Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Neuropathic pain is a severe clinical condition caused by damage to the nervous system. It often feels like a burning, ...

Cannabidiol (CBD) holds great promise as a treatment ... pain, there’s a chance it may work for nerve pain. Neuropathy, or nerve dysfunction, doesn’t always result in nerve pain, or ...

Neuropathic pain is a chronic and debilitating condition that impacts around 10% of the population in both the United States and Europe. Despite advances in understanding the mechanisms of neuropathic ...

A recent study has raised concerns about the widespread prescription of antidepressants for chronic pain, warning that many ...

European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified genetic markers associated with this serious condition.

achieves 60% greater efficacy than the FDA-approved neuropathic pain treatment gabapentin in reducing chemotherapy-induced pain. These results build on earlier successes across various pain models ...

The new preclinical data show that Ketamir-2 is 60% more effective than the FDA-approved neuropathic pain treatment gabapentin in reducing chemotherapy-induced pain. The study used the paclitaxel ...

Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.

Neuropathic pain is a severe clinical ... the cells plays a role in transmitting sensitivity to pain. People with a genetic variant in opioid receptors may need higher doses of painkillers for the ...

MIRA holds the exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a novel, patent-pending oral ketamine analog under investigation to treat neuropathic pain (NP), treatment-resistant ...